Annual Report

Overview

The report presents FY2023 consolidated revenue from operations of 172,374 INR million and describes sustained growth across pharmaceutical and consumer-products businesses. The company established a CSR and ESG Committee to oversee sustainability matters and reported initiatives on renewable energy, water conservation, waste management and climate awareness. Its human-capital section highlights 345894 hours of training and broad employee development programmes. The BRSR includes an independent limited assurance statement covering selected GHG, water, waste, safety and social disclosures.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022-2023
Period: 1 April 2022 – 31 March 2023
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services